{
    "nct_id": "NCT04515004",
    "official_title": "Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer",
    "inclusion_criteria": "A. Initial screening:\n\n* Lesions suspicious for lung cancer\n* Competent to provide consent\n* CBC within normal limits (WNL)\n* liver function test WNL\n* Normal Creatinine clearance as measured by the Cockcroft-Gault equation\n* ECOG Performance status: 0-1\n\nB. Enrollment for treatment with LP:\n\n* Histologically proven and surgically resectable clinical I and II stage NSCLC\nHealthy volunteers allowed\nMust have minimum age of 21 Years",
    "exclusion_criteria": "* Inability to provide informed consent (e.g. cognitive impairment, severe psychiatric disorders)\n* Hypersensitivity to grapes or related products\n* Advance respiratory disease (Post resection FEV1 < 0.8 liters, resting hypoxemia, to ensure pts have adequate reserve to undergo diagnostic procedures and surgical resection)\n* Unstable angina\n* Other concurrent malignancy, excluding non-melanoma type skin cancer\n* Have had a solid organ or bone marrow transplant\n* Pregnancy\n* Breast feeding\n* Systemic corticoid steroid therapy of > 10 mg prednisone equivalent daily\n* Coagulopathy (PT-INR > 1.2, PTT > 40 seconds) or history of bleeding/clotting problems\n* Concurrent use of Grapes or related products\n* Unwilling to refrain from drinking more than 1 glass of wine a day\n* Pts receiving medications known to be modulators of cytochrome P450 3A4 if alternative medication cannot be provided\n* Currently taking other investigational agents\n* Pts with concurrent medical conditions that may interfere with completion of tests, therapy, or the follow up schedule",
    "miscellaneous_criteria": ""
}